Arthur Gilly, Graham Rs Ritchie, Lorraine Southam, Aliki-Eleni Farmaki, Emmanouil Tsafantakis, George Dedoussis, Eleftheria Zeggini
Journal: Human molecular genetics 2017;25(11):2360-2365
PMID: 27146844
Cohort-wide very low-depth whole-genome sequencing (WGS) can comprehensively capture low-frequency sequence variation for the cost of a dense genome-wide genotyping array. Here, we analyse 1x sequence data across the APOC3 gene in a founder population from the island of Crete in Greece (n = 1239) and find significant evidence for association with blood triglyceride levels with the previously reported R19X cardioprotective null mutation (β = -1.09,σ = 0.163, P = 8.2 × 10) and a second loss of function mutation, rs138326449 (β = -1.17,σ = 0.188, P = 1.14 × 10). The signal cannot be recapitulated by imputing genome-wide genotype data on a large reference panel of 5122 individuals including 249 with 4x WGS data from the same population. Gene-level meta-analysis with other studies reporting burden signals at APOC3 provides robust evidence for a replicable cardioprotective rare variant aggregation (P = 3.2 × 10, n = 13 480).
© The Author 2016. Published by Oxford University Press.
Full Text Sources:
Other Literature Sources:
Miscellaneous:
© Copyright 2026, Nutrition Evidence
We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.